Skip to main content

Table 2 ADI fold changes

From: Assessment of the relationship between signal intensities and transcript concentration for Affymetrix GeneChip®arrays

  10-1 nM 1 nM-100 pM 100-10 pM 10-1 pM 1-0.1 pM
  Fold SE Fold SE Fold SE Fold SE Fold SE
Prokaryotic targets only
LysX-5_at 1.55 0.18 1.65 0.17 3.84 0.68 9.53 1.99 10.22 3.16
LysX-M_at 1.14 0.22 1.45 0.22 4.06 0.73 8.73 2.31 10.18 2.83
LysX-3_at 1.38 0.23 1.25 0.13 2.74 0.43 7.97 1.83 9.82 2.14
PheX-5_at 1.44 0.24 1.43 0.15 2.74 0.24 6.90 0.94 10.23 1.96
PheX-M_at 1.29 0.27 1.38 0.18 2.46 0.24 7.66 0.88 9.69 1.65
PheX-3_at 1.22 0.34 1.15 0.21 2.24 0.33 7.18 1.21 9.03 1.57
DapX-5_at 1.53 0.19 1.76 0.25 4.30 0.87 8.65 1.99 8.97 1.89
DapX-M_at 1.35 0.24 1.62 0.17 3.84 0.66 8.50 2.14 10.22 2.33
DapX-3_at 1.14 0.20 1.76 0.23 4.19 0.75 8.85 1.93 10.18 2.60
ThrX-5_at 1.36 0.39 1.56 0.28 3.72 0.66 8.38 1.82 10.52 2.34
ThrX-M_at 1.33 0.23 1.56 0.20 4.06 0.75 9.04 2.05 9.96 2.92
ThrX-3_at 0.99 0.40 1.12 0.29 2.94 0.60 8.25 2.31 10.10 2.83
Fixed eukaryotic background
LysX-5_at 1.45 0.22 2.76 0.44 6.48 1.25 9.58 1.91 8.21 2.20
LysX-M_at 0.94 0.16 2.19 0.43 7.15 1.72 6.99 1.97 3.39 0.82
LysX-3_at 1.10 0.14 1.53 0.22 5.37 0.96 6.71 1.20 4.83 0.79
PheX-5_at 1.10 0.11 1.93 0.25 4.55 0.32 9.28 1.26 29.65 6.72
PheX-M_at 1.05 0.17 1.49 0.21 4.63 0.65 9.75 1.20 34.84 20.84
PheX-3_at 0.98 0.15 1.59 0.27 6.12 0.88 9.75 1.46 22.89 4.01
DapX-5_at 1.25 0.15 2.88 0.49 5.87 1.28 9.59 2.59 6.25 2.55
DapX-M_at 1.08 0.15 2.57 0.45 6.01 1.33 8.00 1.41 2.28 0.18
DapX-3_at 1.12 0.11 2.63 0.46 9.26 1.32 8.25 1.99 175.29 16.17
ThrX-5_at 1.11 0.17 2.09 0.37 6.14 1.34 7.90 1.57 7.37 1.26
ThrX-M_at 1.12 0.14 2.19 0.37 6.35 1.40 9.98 1.86 24.77 24.52
ThrX-3_at 0.63 0.10 1.75 0.33 5.31 0.73 9.62 2.01 11.32 1.11
  1. The table shows ADI fold changes between consecutive tenfold dilutions (excluding negative ADIs) and standard errors in the absence (upper) and presence (lower) of 0.5 g/l eukaryotic background.